A detailed history of Sentry LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sentry LLC holds 56,074 shares of MRK stock, worth $7.05 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
56,074
Previous 56,975 1.58%
Holding current value
$7.05 Million
Previous $6.21 Billion 19.12%
% of portfolio
1.39%
Previous 1.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $102,029 - $118,886
-901 Reduced 1.58%
56,074 $7.4 Billion
Q4 2023

Feb 01, 2024

BUY
$100.18 - $109.02 $5.71 Million - $6.21 Million
56,975 New
56,975 $6.21 Million
Q3 2023

Mar 06, 2024

BUY
$102.95 - $114.33 $248,315 - $275,763
2,412 Added 4.4%
57,269 $5.9 Billion
Q2 2023

Mar 06, 2024

BUY
$108.61 - $118.38 $5,213 - $5,682
48 Added 0.09%
54,857 $6.33 Billion
Q1 2023

Mar 06, 2024

SELL
$102.94 - $114.86 $222,968 - $248,786
-2,166 Reduced 3.8%
54,809 $5.83 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sentry LLC Portfolio

Follow Sentry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry LLC with notifications on news.